Overview

Aerosolized Antibiotics in the Treatment of Ventilator Associated Pneumonia

Status:
Unknown status
Trial end date:
2017-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if administering inhaled antibiotics directly into the lungs in conjunction with intravenous (IV) antibiotics leads to better outcomes and decreased recurrence of ventilator associated pneumonia (VAP) when compared to IV antibiotics alone.
Phase:
Phase 4
Details
Lead Sponsor:
Wright State University
Treatments:
Anti-Bacterial Agents
Tobramycin
Vancomycin